Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2008Journal of Clinical OncologyOpen Access

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJim CassidyUniversity of GlasgowSCStephen ClarkeThe University of SydneyEDEduardo Díaz‐RubioHospital Clínico San Carlos

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cassidy et al. (2008) studied this question.

synapsesocial.com/papers/69d7cd4e319e71454dbedab1https://doi.org/10.1200/jco.2007.14.9898
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer2000 · 3,834 citations
  2. 2Capecitabine as Adjuvant Treatment for Stage III Colon Cancer2005 · 1,257 citations
  3. 3Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study2001 · 1,040 citations
  4. 4Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial2007 · 270 citations
  5. 5Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Leucovorin Plus Oxaliplatin in Metastatic Colorectal Cancer: A Final Report of the AIO Colorectal Study Group2007 · 281 citations